Intriguingly, treatment with HDAC inhibitors also suppresses ERα expression in ER+ breast cancer cell lines [36] while divergent conclusions have been reached concerning their impact on ER- cells [37,38]. This evidence concerns the gene ESR1 and breast cancer.